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Abstract Various types of synthetic oligonucleotide duplexes
against the Photinus luciferase gene were tested on their
induction of the sequence-specific RNA interference (RNAi)
activity in transfected human cells. Results indicate that RNA
duplexes with ribonucleotide 3P overhangs rather than those with
deoxyribonucleotide 3P overhangs induce more efficient RNAi
activity, and that sense-stranded DNA/antisense-stranded RNA
hybrids induce a moderate RNAi activity. These results suggest
that there is a difference in the potential of oligonucleotide
duplexes to be RNAi mediators, i.e. short interfering RNAs
(siRNAs), between human RNAi and invertebrate RNAi. The
data further show that different siRNAs induce different levels
of RNAi. % 2002 Published by Elsevier Science B.V. on behalf
of the Federation of European Biochemical Societies.
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1. Introduction
RNA interference (RNAi) is the process of sequence-specif-
ic posttranscriptional gene silencing triggered by double-
stranded RNAs (dsRNAs) homologous to the silenced genes.
This intriguing phenomenon has been found in various species
including £ies, worms, protozoa, vertebrates and higher plants
(reviewed in [1^4]). The majority of studies on the molecular
mechanism underlying RNAi activity have been conducted
using Drosophila and Caenorhabditis elegans, and demon-
strated that 21^25-nucleotide (nt) RNA fragments, referred
to as short interfering RNAs (siRNAs), are essential se-
quence-speci¢c mediators of RNAi [5^7], and that siRNAs
are generated from long dsRNAs by digestion with an RNase
III-like nuclease, Dicer [8,9]. It is also noteworthy that
although the mechanism underlying RNAi activity has not
been completely elucidated, RNAi has already become a
powerful reverse genetic method for suppressing the expres-
sion of a gene of interest in various species (reviewed in
[3,10]).
In mammalian RNAi, it was initially thought that RNAi
might occur only in oocytes [11] and preimplantation embryos
[12]. Mammalian cells in general possess a rapid and non-
speci¢c RNA degradation pathway involving the sequence-
non-speci¢c RNase, RNase L [13], and a rapid translation
inhibition pathway involving the interferon-inducible,
dsRNA-activated protein kinase, PKR, both of which can
be activated by long dsRNAs (s 30 bp) [14^16]. Thus, these
rapid responses to long dsRNAs may mask the sequence-spe-
ci¢c RNAi activity in mammalian cells [17] except in undi¡er-
entiated cells [18,19] as well as di¡erentiated cells that possibly
lack PKR [20]. Elbashir et al. [21] have recently demonstrated
that synthetic 21-nucleotide siRNA duplexes can speci¢cally
inhibit the expression of cognate genes in cultured mammalian
cells. RNAi induction with synthetic oligonucleotide duplexes
seems to have paved the way for molecular analyses of mam-
malian RNAi and for its possible application to mammalian
reverse genetic studies [22].
In this study, I investigated the e¡ects of various types of
oligonucleotide duplexes targeting the exogenous reporter
gene, Photinus luciferase, on the suppression of the expression
of the gene, i.e. RNAi, and examined the properties of the
allowable oligonucleotide duplexes for being RNAi mediators
in mammalian cells.
2. Materials and methods
2.1. Cell culture
HeLa and NTera2D1 cells were grown at 37‡C in Dulbecco’s modi-
¢ed Eagle’s medium (Sigma) supplemented with 10% fetal bovine
serum (Life Technologies), 100 U/ml penicillin (Life Technologies),
and 100 Wg/ml streptomycin (Life Technologies) in a 5% CO2-humidi-
¢ed chamber.
2.2. Preparation of oligonucleotide duplex
Oligonucleotides synthesized in this study are indicated in Table 1.
All the oligonucleotides including the GL3 oligonucleotides [21] were
obtained from GENSET OLIGOS. Since siRNA duplexes with 2-nt 3P
overhangs appeared to be the most e⁄cient inducers of RNAi [21,23],
the synthesized oligonucleotides possessed a ribo-uridine or deoxy-
thymidine dinucleotide sequence at the 3P ends; thus, the resultant
duplexes contain 2-nt 3P overhangs (Table 1). For preparation of
duplexes, sense- and antisense-stranded oligonucleotides (20 WM
each) were mixed together in annealing bu¡er (30 mM HEPES pH
7.0, 100 mM potassium acetate, and 10 mM magnesium acetate),
heat-denatured at 90‡C for 3 min, and annealed at 37‡C overnight.
2.3. Transfection and luciferase assay
The day before transfection, cells were trypsinized, diluted with the
fresh medium without antibiotics, and seeded into 24-well culture
plates (approximately 0.5U1035 cells/well in 0.5 ml of the culture
medium). Cotransfection with reporter plasmids and synthetic oligo-
nucleotides was carried out using a DOSPER liposomal transfection
reagent (Roche) as described by the manufacturer. Before cotransfec-
tion, the culture medium was replaced with 0.5 ml of OPTI-MEM I
(Life Technologies), and to each well, 0.25 Wg of pGL3-Control plas-
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mid (Promega), 0.05 Wg of phRL-TK plasmid (Promega), and 0.24 Wg
of oligonucleotide duplexes were applied. Cells were incubated for 4 h
at 37‡C. After the 4-h incubation, 0.5 ml of the fresh culture medium
without antibiotics was added, and further incubation at 37‡C was
carried out. Cell lysate was prepared 24 h after transfection and lu-
ciferase expression assay was carried out using a Dual-Luciferase
reporter assay system (Promega) according to the directions provided
by the manufacturer.
3. Results and discussion
3.1. RNAi induction by various types of synthetic
oligonucleotide duplexes
In order to realize e⁄cient RNAi induction by synthetic
oligonucleotide duplexes in mammalian cells, it is important
to know the properties of the duplexes conferring a strong
RNAi activity. Here I constructed various types of synthetic
oligonucleotide duplexes against the Photinus luciferase gene,
introduced the duplexes together with a pGL3-control plas-
mid carrying the Photinus luciferase gene and a phRL-TK
plasmid carrying the Renilla luciferase gene as a control into
cultured human cells, and examined the e¡ect of the duplexes
on the suppression of the expression of Photinus luciferase, i.e.
on the induction of RNAi.
Fig. 1 shows the results of dual-luciferase assay. When the
GL3 and GL3UU duplexes, which are identical except for
their 3P ends, i.e. containing 2-nt deoxy-thymidine (TT) and
2-nt ribo-uridine (UU) 3P overhangs, respectively, were intro-
duced together with the reporter plasmids into HeLa cells, a
human epithelial cell line, results indicate that there is a di¡er-
ence in the degree of silencing of the Photinus luciferase gene
between these duplexes: the GL3UU duplex appears to induce
a stronger RNAi activity than the GL3 duplex. Similar results
were also obtained when NTera2D1 cells, a human embryonal
carcinoma cell line, were used. In a previous study [21], the
GL2 and uGL2 duplexes, which, like the GL3 and GL3UU
duplexes, possessed the same dsRNAs with TT and UU
3P overhangs, respectively, appeared to induce similar levels
of RNAi activity in mammalian cells. The di¡erences in out-
come of the induction by the duplexes having TT and UU 3P
overhangs between the previous and present studies might be
attributed to the di¡erences in the target sites (genes) and/or
in the culture and cell conditions between the studies. Since
the data described above were reproducible in this study, I
further analyzed the di¡erence in the RNAi induction between
the GL3 and GL3UU duplexes in the present system.
When the sense- or antisense-stranded elements of the GL3
and GL3UU duplexes were swapped, the resultant sense-
stranded GL3/antisense-stranded GL3UU (ssGL3/asGL3UU)
and ssGL3UU/asGL3 duplexes appeared to induce a similar
level of RNAi activity to that of the GL3UU and GL3 du-
plexes, respectively, in HeLa cells (Fig. 1). Similar results,
except for the ssGL3UU/asGL3 duplex, were obtained when
NTera2D1 cells were used; the RNAi induction level by the
ssGL3UU/asGL3 duplex appeared to be lower than that by
the GL3 duplex in NTera2D1 cells. The di¡erence in pro¢les
of the RNAi induction by the ssGL3UU/asGL3 duplex be-
tween HeLa and NTera2D1 cells may re£ect the di¡erence in
the contribution of cellular proteins associated with siRNAs
to induction of RNAi between these cell lines.
I also constructed DNA/RNA hybrids, the ssDNA/asGL3
and ssDNA/asGL3UU hybrids, and examined their e¡ects on
RNAi induction. Interestingly, results indicated that the
ssDNA/asGL3UU hybrid induced a moderate level of
RNAi activity in either HeLa or NTera2D1 cells, whereas
the ssDNA/asGL3 hybrid induced little or no RNAi activity
in both cells (Fig. 1). In addition, the ssDNA/asGL3UU hy-
brid appears to induce a more e⁄cient RNAi activity than the
GL3 duplex. These results suggest that the nature of RNA in
the antisense-stranded elements of the duplexes is important
for mediating RNAi. It should also be pointed out that in
C. elegans, DNA/RNA hybrids appear to hardly induce
RNAi activity [6]. Therefore, these observations suggest that
there is a di¡erence in the potential of oligonucleotide
duplexes to be RNAi mediators in human cells and those in
C. elegans. It is of great interest to determine the di¡erence in
the oligonucleotide duplexes having potential for being RNAi
mediators between human and invertebrate cells; to elucidate
it, further extensive studies must be conducted.
The above observations indicate the possibility that RNA/
DNA hybrids composed of sense RNA oligomers and anti-
sense DNA oligomers that terminate in ribonucleotides at
3P ends may induce RNAi to some degree in mammalian cells.
To clarify this possibility, two DNA^RNA mixed oligomers
corresponding to asGL3UU were synthesized (Table 1): one
is GL3DNA-UU that is 19-nt DNA linked with 2-nt RNA at
the 3P end, and the other is GL3DNA3R-UU that is 16-nt
DNA linked with 5-nt RNA at the 3P end. The GL3DNA-UU
and GL3DNA3R-UU oligonucleotides were annealed with
the ssGL3UU oligonucleotide and the resultant RNA/DNA
hybrids together with reporter plasmids were introduced into
Table 1
Synthesized oligonucleotides in this study
Name Sequence Tm (‡C)
ssGL3a 5P-rCUUrArCrGrCUrGrArGUrArCUUrCrGrATT-3P 46
asGL3a 5P-UrCrGrArArGUrArCUrCrArGrCrGUrArArGTT-3P 46
ssGL3UU 5P-rCUUrArCrGrCUrGrArGUrArCUUrCrGrAUU-3P 46
asGL3UU 5P-UrCrGrArArGUrArCUrCrArGrCrGUrArArGUU-3P 46
ssDNA 5P-CTTACGCTGAGTACTTCGATT-3P 46
GL3DNA-UU 5P-TCGAAGTACTCAGCGTAAGUU-3P 46
GL3DNA3R-UU 5P-TCGAAGTACTCAGCGTrArArGUU-3P 46
ssLa2 5P-rGrGrArArGrArCrGrCrCrArArArArArCrAUrAUU-3P 51
asLa2 5P-UrAUrGUUUUUrGrGrCrGUrCUUrCrCUU-3P 51
ssLa21 5P-rArCrCrGrCUrGrGrArGrArGrCrArArCUrGrCUU-3P 58
asLa21 5P-rGrCrArGUUrGrCUrCUrCrCrArGrCrGrGUUU-3P 58
ssLa100 5P-rGrCrArGUUrGrCrGrCrCrCrGrCrGrArArCrGUU-3P 68
asLa100 5P-rCrGUUrCrGrCrGrGrGrCrGrCrArArCUrGrCUU-3P 68
‘r’ pre¢xed to G, A, and C represents ribonucleotide, and U indicates ribo-uridine.
aThese oligonucleotides were used in a previous study [21].
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either HeLa or NTera2D1 cells, and the expression of lucif-
erase was then examined. Results show that little or no RNAi
activity was induced by these hybrids in either HeLa or NTer-
a2D1 cells (Fig. 1). In this study, therefore, the GL3UU and
ssGL3/asGL3UU duplexes appear to induce the most e⁄cient
RNAi activity of all the duplexes examined. This suggests that
a double-stranded form of RNA and ribonucleotide 3P over-
hangs, particularly those on the antisense single-stranded side,
are important for maximizing the e⁄ciency of synthetic oli-
gonucleotide duplexes to induce RNAi in mammalian cells.
As for the importance of the ribonucleotide 3P termini on the
antisense single-stranded side of the duplexes, it may be asso-
ciated with RNA-dependent RNA polymerase activity [24].
3.2. SiRNA-dependent RNAi activity
I examined if there were any di¡erences in the RNAi activ-
ity among various siRNA duplexes that recognized di¡erent
sequences in a cognate gene. To address the question, I con-
structed three new 21-nt RNA duplexes against the Photinus
luciferase gene other than the GL3UU duplex, and tested the
e¡ects of these four RNA duplexes on the induction of RNAi
in either HeLa or NTera2D1 cells using the same procedure as
described above. The sequences of the RNA oligomers syn-
thesized as siRNAs are shown in Table 1, and their positions
on the target gene, the Photinus luciferase gene, are shown in
Fig. 2. Note that the synthesized RNA oligomers possess a
ribo-uridine dinucleotide sequence at the 3P ends to maximize
the e⁄ciency of the oligomers for induction of RNAi; thus,
the resultant RNA duplexes contain 2-nt ribo-uridine 3P over-
hangs. Fig. 3 shows the results of the dual-luciferase assay.
Interestingly, a di¡erence in the degree of silencing of the
Photinus luciferase gene was observed among the RNA du-
plexes used: the La2, La21, GL3UU, and La100 duplexes at a
concentration of 40 nM decreased the Photinus luciferase ex-
Fig. 1. RNAi activities induced by various types of oligonucleotide
duplexes. Various oligonucleotide duplexes together with pGL3-con-
trol and phRL-TK plasmids carrying Photinus and Renilla luciferase
reporter genes, respectively, were cotransfected into either HeLa or
NTera2D1 cells. Twenty-four hours after transfection, cell lysate
was prepared and dual-luciferase assay was carried out. Ratios of
normalized target (Photinus) luciferase activity to control (Renilla)
luciferase activity are indicated: the ratios of luciferase activity de-
termined in the presence of duplexes are normalized to the ratio ob-
tained for a control in the absence of duplex (No duplex). Open
and dotted bars indicate the data of HeLa and NTera2D1 cells, re-
spectively. Data are averages of at least three independent experi-
ments. Error bars represent standard deviations.
Fig. 2. Nucleotide sequence of part of pGL3-control plasmid. Se-
quence of pGL3-control plasmid from nucleotide positions 251^610
is presented (the nucleotide positions are based on the numbering
system used in the technical manual provided by the manufacturer).
The sequences homologous to synthetic siRNAs used are indicated
by boxes, and the name of the siRNA is indicated under the box.
Asterisks indicate the ¢rst methionine codon of the Photinus lucifer-
ase gene.
Fig. 3. Di¡erent RNAi activities induced by di¡erent siRNAs. Syn-
thetic siRNAs together with pGL3-control and phRL-TK plasmids
were cotransfected into either HeLa or NTera2D1 cells. Pre¢xes at-
tached to the name of siRNA, i.e. ds, ss and as, represent double-
stranded (duplex), and sense and antisense single-stranded siRNAs,
respectively. Twenty-four hours after transfection, cell lysate prepa-
ration and dual-luciferase assay were carried out. Ratios of normal-
ized target (Photinus) luciferase activity to control (Renilla) lucifer-
ase activity are indicated as in Fig. 1. Open and dotted bars
indicate the data of HeLa and NTera2D1 cells, respectively. Data
are averages of at least three independent experiments. Error bars
represent standard deviations.
Fig. 4. Dose-dependent inhibition of target luciferase in HeLa cells.
The pGL3-control and phRL-TK plasmids were cotransfected with
an increasing amount of each siRNA duplex, from 1 pM to 10 nM.
Twenty-four hours after transfection, dual-luciferase assay was car-
ried out. Data are presented as normalized ratios of target (Photi-
nus) luciferase activity to control (Renilla) luciferase activity as in
Fig. 1. Open diamond, square, triangle and circle indicate the ratios
for La2, La21, GL3UU and La100 duplexes, respectively.
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Fig. 5. Predicted secondary structures. The nucleotide sequences of pGL3-control plasmid from nucleotide positions 251^350 (A), 301^400 (B),
391^490 (C) and 541^640 (D) are presented. The sequences were analyzed by the GENETYX-MAC 8.0 computer program. Putative hydrogen
bonds are indicated by solid bars. Figures and arrows indicate the nucleotide position based on the numbering system used in the technical
manual provided by the manufacturer. The sequences homologous to La2 (A), La21 (B), GL3UU (C) and La100 (D) siRNAs used in this
study are indicated by circles.
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pression level up to 2.3%, 48.9%, 7.5%, and 34.4%, respec-
tively, in HeLa cells. Because similar results were also ob-
served in NTera2D1 cells, the results may be common to
various human or mammalian cells.
I further examined the e¡ects of various doses of the RNA
duplexes on the Photinus luciferase expression in the trans-
fected cells. As shown in Fig. 4, results indicate that a dose-
dependent, sequence-speci¢c RNAi activity occurs in either
HeLa or NTera2D1 cells (data not shown). In addition, it
appears that the La2 and GL3UU duplexes can inhibit the
Photinus luciferase expression at a concentration as low as
0.1 nM in this system, whereas the La21 and La100 duplexes
slightly suppress the expression at the same concentration.
Together with the above observations (Fig. 3), these results
suggest that the La2 and GL3UU duplexes induce a relatively
stronger RNAi activity than the La21 and La100 duplexes.
The evidence presented above suggests that a siRNA-de-
pendent RNAi activity occurs in cultured human cells; it pos-
sibly occurs in various mammalian cells including human
cells. It is of great interest to determine the reason why such
a di¡erence in the RNAi activity induced by various siRNAs
duplexes occurs. I ¢rst examined whether there was any asso-
ciation between RNAi activity and either the sequence simi-
larity or melting temperature (Tm) of the siRNA used, but no
signi¢cant association was observed between them. For other
possible explanations, the following are conceivable: (i) there
may be some di¡erence in the a⁄nity between cellular siRNA-
binding protein(s) [25] and each of the siRNA duplexes used;
(ii) the secondary and/or tertiary structures of target mRNA
may participate in the induction of distinct RNAi activities.
As for the latter possibility, when the nucleotide sequence of
Photinus luciferase was analyzed using the GENETYX-MAC
8.0 computer program, the target sequence of either La21 or
La100 siRNA in the luciferase gene was predicted to form a
stem structure with 12 hydrogen bonds, whereas the La2 and
GL3UU sequences were predicted to form a few hydrogen
bonds in them (Fig. 5). To elucidate whether the predicted
structures can be actually formed in the RNA transcript,
and whether the RNA structures are indeed associated with
the RNAi activity, more extensive studies are required to be
conducted.
Finally, although the molecular mechanism underlying the
siRNA-dependent RNAi activity is still unknown, the data
presented here may provide signi¢cant information concern-
ing synthetic siRNAs as a novel tool for mammalian reverse
genetic studies. Selection of a suitable siRNA for the e⁄cient
suppression of the expression of a gene of interest is necessary.
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